Carboplatin and hypomagnesemia: Is it really a problem?

Autor: Gaughran, Gregory¹ (AUTHOR), Qayyum, Kiran² (AUTHOR), Smyth, Lillian² (AUTHOR), Davis, Alison^1,2 (AUTHOR) Alison.Davis@act.gov.au

Publikováno v: Asia Pacific Journal of Clinical Oncology. Dec2021, Vol. 17 Issue 6, p478-485. 8p.

Improving regional access: Phase 1 teletrials in the era of COVID‐19.

Autor: Gaughran, Gregory¹ (AUTHOR) Gregorygaughran@gmail.com, Zalcberg, John^1,2 (AUTHOR), Hawkins, Cheryl‐Ann¹ (AUTHOR), Shackleton, Mark^1,3 (AUTHOR), Voskoboynik, Mark^1,3 (AUTHOR)

Publikováno v: Asia Pacific Journal of Clinical Oncology. Aug2021, Vol. 17 Issue 4, p416-417. 2p.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vedolizumab in combined immune checkpoint therapy-induced infliximab-refractory colitis in a patient with metastatic melanoma: A case report.

Autor: Randhawa M; Department of Medical Oncology, Canberra Region Cancer Centre, The Canberra Hospital, Canberra, ACT 2605, Australia., Gaughran G; Department of Medical Oncology, Canberra Region Cancer Centre, The Canberra Hospital, Canberra, ACT 2605, Australia., Archer C; Department of Medical Oncology, Canberra Region Cancer Centre, The Canberra Hospital, Canberra, ACT 2605, Australia., Pavli P; Department of Gastroenterology, The Canberra Hospital, Canberra, ACT 2605, Australia., Morey A; Department of Anatomical Pathology, The Canberra Hospital, Canberra, ACT 2605, Australia., Ali S; Department of Medical Oncology, Canberra Region Cancer Centre, The Canberra Hospital, Canberra, ACT 2605, Australia., Yip D; Department of Medical Oncology, Canberra Region Cancer Centre, The Canberra Hospital, Canberra, ACT 2605, Australia.

Publikováno v: World journal of clinical oncology [World J Clin Oncol] 2019 Oct 24; Vol. 10 (10), pp. 350-357.